These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 8919478

  • 21. [Detection and treatment of ductal carcinoma of the breast].
    Semiglazov VV, Tabagua TT, Matsko DE.
    Vopr Onkol; 2011; 57(6):699-701. PubMed ID: 22416383
    [No Abstract] [Full Text] [Related]

  • 22. Hormone receptors in breast cancer.
    Br Med J; 1978 Jul 08; 2(6130):77-8. PubMed ID: 208709
    [No Abstract] [Full Text] [Related]

  • 23. Solving the puzzle of hormone-dependent breast cancer.
    Santen RJ.
    Trans Am Clin Climatol Assoc; 1992 Jul 08; 103():164-75. PubMed ID: 1413376
    [No Abstract] [Full Text] [Related]

  • 24. Differential regulation of c-fos expression in estrogen-induced hamster renal tumors compared with kidney not due to creation of an estrogen-response element by point mutation in the gene's flanking sequence.
    Sarabia SF, Liehr JG.
    Mol Carcinog; 1999 Apr 08; 24(4):255-62. PubMed ID: 10326862
    [Abstract] [Full Text] [Related]

  • 25. [Estrogen and progesterone receptors in carcinoma of the breast].
    Musiani P, Piantelli M, Dina MA.
    Pathologica; 1979 Apr 08; 71(1011):1-7. PubMed ID: 450473
    [No Abstract] [Full Text] [Related]

  • 26. Macromolecular binding of dexamethasone as evidence for the presence of mineralocorticoid receptor in human breast cancer.
    Martin PM, Rolland PH, Raynaud JP.
    Cancer Res; 1981 Mar 08; 41(3):1222-6. PubMed ID: 6780185
    [No Abstract] [Full Text] [Related]

  • 27. Biochemical basis of breast cancer treatment by androgens and progestins.
    Rochefort H.
    Prog Clin Biol Res; 1984 Mar 08; 142():79-95. PubMed ID: 6538685
    [No Abstract] [Full Text] [Related]

  • 28. Hormone receptors in the management of breast cancer.
    Osborne CK.
    Tex Med; 1984 Nov 08; 80(11):30-2. PubMed ID: 6515569
    [No Abstract] [Full Text] [Related]

  • 29. Pure and mixed hormone receptor positive breast tumors: are they different from therapeutic point of view?
    Altundag K, Altundag O, Gunduz E, Silay YS, Boruban C.
    Med Hypotheses; 2005 Nov 08; 65(1):194. PubMed ID: 15893141
    [No Abstract] [Full Text] [Related]

  • 30. Risk factors and hormone-receptor status: epidemiology, risk-prediction models and treatment implications for breast cancer.
    Chen WY, Colditz GA.
    Nat Clin Pract Oncol; 2007 Jul 08; 4(7):415-23. PubMed ID: 17597706
    [Abstract] [Full Text] [Related]

  • 31. NCCN Guideline update: Breast Cancer Version 1.2004.
    National Comprehensive Cancer Network.
    J Natl Compr Canc Netw; 2004 May 08; 2(3):183-4. PubMed ID: 19795602
    [No Abstract] [Full Text] [Related]

  • 32. Differential screening and suppression subtractive hybridization identified genes differentially expressed in an estrogen receptor-positive breast carcinoma cell line.
    Kuang WW, Thompson DA, Hoch RV, Weigel RJ.
    Nucleic Acids Res; 1998 Feb 15; 26(4):1116-23. PubMed ID: 9461476
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype.
    Rakha EA, El-Sayed ME, Green AR, Paish EC, Powe DG, Gee J, Nicholson RI, Lee AH, Robertson JF, Ellis IO.
    J Clin Oncol; 2007 Oct 20; 25(30):4772-8. PubMed ID: 17876012
    [Abstract] [Full Text] [Related]

  • 35. Lack of synergy between estrogen and progesterone on local IGF-I, IGFBP-3 and IGFBP-2 secretion by both hormone-dependent and hormone-independent breast cancer explants in vitro. Effect of tamoxifen and mifepristone (RU 486).
    Milewicz T, Gregoraszczuk EL, Sztefko K, Augustowska K, Krzysiek J, Ryś J.
    Growth Horm IGF Res; 2005 Apr 20; 15(2):140-7. PubMed ID: 15809018
    [Abstract] [Full Text] [Related]

  • 36. [Are the new breast cancer subtypes (luminal A, B etc.) of practical impact? Yes].
    Stöger H.
    Dtsch Med Wochenschr; 2013 Oct 20; 138(41):2096. PubMed ID: 24085364
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Different expression patterns of Bcl-2 family genes in breast cancer by estrogen receptor status with special reference to pro-apoptotic Bak gene.
    Eguchi H, Suga K, Saji H, Toi M, Nakachi K, Hayashi SI.
    Cell Death Differ; 2000 May 20; 7(5):439-46. PubMed ID: 10800077
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.